Sign in

CIK 0001719714 · Non-accelerated filer<br>Smaller reporting company

Mereo BioPharma Group plc

Sign in to watch
Ticker
MREO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
4403330237300
Business address
ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
  1. 144 Insider Sale of Securities
  2. 8-K Event Shareholder vote results
  3. EFFECT Other Notice of Effectiveness
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. UPLOAD Other SEC-generated Letter
  6. S-3 Offering Registration Statement
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. ARS Other Annual Report to Security Holders
  10. DEF 14A Proxy Proxy Statement
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 8-K Event Material agreement
  13. 10-K Report Annual Report
  14. 8-K Event Results of operations
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 4 Insider Changes in Ownership

Page 8 of 23 · 441 filings